Table 2.

Comparison of computer-assigned ICD-O-3 classification to coder-assigned classification for 1493 patients with lymphoma reported to the Greater Bay Area Cancer Registry 1988 to 1994, including case counts and positive predictive value (%)

Registry generated ICD-O-3 classificationCoder-assigned ICD-O-3 classification, n (%)
Total, n (%)
NOS95969670967196739675968096849687969096919695969896999700970297099714972797289835
NOS133 (57)13 (6)7 (3)9 (4)20 (9)12 (5)6 (3)1 (0)9 (4)9 (4)6 (3)7 (3)1 (0)233 (100)
96705 (5)77 (79)8 (8)4 (4)1 (1)1 (1)1 (1)1 (1)98 (700)
96712 (25)5 (63)1 (13)8 (100)
96735 (19)5 (19)14 (52)2 (7)1 (4)27 (100)
96755 (6)1 (1)52 (62)8 (10)1 (1)10 (12)1 (1)3 (4)1 (1)1 (1)1 (1)84 (100)
968018 (4)2 (0)3 (1)1 (0)410 (88)11 (2)1 (0)1 (0)2 (0)4 (1)3 (1)8 (2)464 (100)
968415 (11)6 (4)114 (82)1 (1)1 (1)2 (1)139 (700)
96873 (12)1 (4)22 (85)26 (100)
96901 (4)2 (8)1 (4)1 (4)2 (8)1 (4)3 (13)8 (33)4 (17)1 (4)24 (100)
96913 (3)5 (4)3 (3)94 (82)4 (3)6 (5)115 (100)
96953 (2)1 (1)1 (1)1 (1)1 (1)3 (2)5 (4)110 (88)125 (100)
96982 (3)1 (1)1 (1)8 (10)4 (5)1 (1)60 (78)77 (700)
96992 (100)2 (100)
97002 (5)39 (89)2 (5)1 (2)44 (100)
97011 (100)1 (100)
97022 (18)2 (18)2 (18)3 (27)1 (9)1 (9)11 (100)
97091 (100)0 (0)1 (100)
97272 (14)9 (64)3 (21)14 (100)
Total1993105142771461140299124135831141941211411,493
  • NOTE: Malignant lymphoma, NOS (codes 9590 and 9591); composite Hodgkin's lymphoma and NHL (code 9596); Hodgkin's lymphoma, NOS (code 9650); Hodgkin's lymphoma, lymphocyte rich (code 9651); Hodgkin's lymphoma, mixed cellularity, NOS (code 9652); Hodgkin's lymphoma, lymphocyte depletion, NOS (code 9653); Hodgkin's lymphoma, lymphocyte depletion, reticular (code 9655); Hodgkin's lymphoma, nodular lymphocyte predominance (code 9659); Hodgkin's lymphoma, nodular sclerosis, NOS (code 9663); Hodgkin's lymphoma, nodular sclerosis, cellular phase (code 9664); Hodgkin's lymphoma, nodular sclerosis, grade 2 (code 9667); malignant lymphoma, small B lymphocytic, NOS (code 9670); malignant lymphoma, lymphoplasmacytic (code 9671); mantle cell lymphoma (code 9673); malignant lymphoma, mixed small and large cell, diffuse (code 9675); malignant lymphoma, large B cell, diffuse, NOS (code 9680); malignant lymphoma, large B cell, diffuse, immunoblastic, NOS (code 9684); Burkitt lymphoma, NOS (code 9687); splenic marginal zone B-cell lymphoma (code 9689); follicular lymphoma, NOS (code 9690); follicular lymphoma, grade 2 (code 9691); follicular lymphoma, grade 1 (code 9695); follicular lymphoma, grade 3 (code 9698); marginal zone B-cell lymphoma, NOS (code 9699); mycosis fungoides (code 9700); mature T-cell lymphoma, NOS (code 9702); angioimmunoblastic T-cell lymphoma (code 9705); s.c. panniculitis-like T-cell lymphoma (code 9708); cutaneous T-cell lymphoma, NOS (code 9709); anaplastic large cell lymphoma, T-cell and null cell type (code 9714); NK/T-cell lymphoma, nasal and nasal type (code 9719); precursor cell lymphoblastic lymphoma, NOS (code 9727); precursor T-cell lymphoblastic lymphoma (code 9729); Waldenstrom macroglobulinemia (code 9761); B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (code 9823); adult T-cell leukemia/lymphoma (HTLV-1 positive, code 9827); acute myelomonocytic leukemia (code 9867); lymphoproliferative disorder, NOS (code 9970).